Developing antibodies for colorectal cancer and various other conditions.
Industry: Other
First Day Return: +22.4%
Industry: Other
IPO Data | |
---|---|
IPO File Date | 02/02/2015 |
Offer Price | $19.00 |
Price Range $18.00 - $20.00 | |
Offer Shares (mm) | 4.0 |
Deal Size ($mm) | $76 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/14/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $76 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Austin, TX, United States |
Founded | 2005 |
Employees at IPO | 56 |
Website www.xbiotech.com |